Register
FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs |
Journal Updates
eMediNexus Coverage from: 
FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs
eMediNexus,  09 August 2018
remove_red_eye 553 Views
#Pathology and Lab Medicine #Pharmacist


comment                   
        



The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation. This new approval pathway was created to expedite the development and review of a generic drug for products that lack competition. Potassium chloride is an oral treatment that is indicated for the treatment and prevention of hypokalemia (low potassium blood levels) in patients who are on diuretics, and when dietary management with potassium-rich foods is insufficient or diuretic dose reduction is not possible.


Comments

Comments on eMediNexus are moderated. We retain the right to remove any comments at our sole discretion.